Drug Trial Radar · NCT00257712
SMART: Somatotrophics, Memory, and Aging Research Trial
Last checked: Nov 20, 2026Latest source record: Dec 19, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
151
Actual
Start
Feb 2006
Primary completion
Dec 2011
Study completion Dec 2011
Sponsor
- Lead sponsor
- University of WashingtonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- First posted
- Nov 23, 2005
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 55 years, up to 90 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the SMART study was to better understand whether the body's own production of growth hormone (GH) would improve memory and problem solving ability, or cognitive function. The study was a double blind, placebo-controlled study of the cognitive effects of growth hormone releasing hormone (GHRH) in healthy older men and women and in those with mild cognitive impairment (MCI).
Conditions
- Aging
- Mild Cognitive Impairment
Interventions
TH9507 human growth hormone releasing hormone (GHRH)Drug
1mg subcutaneous injection given daily for 20 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in declarative memory, including total recall scores on three tests of memory and on dual task response time (RT), a test of executive function.Time frame: Baseline, 10, 20, and 30 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Washington
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.